<DOC>
	<DOCNO>NCT02642237</DOCNO>
	<brief_summary>To evaluate bacterial-viral interaction LPS Fluenz model sepsis ( bacterial ) Influenza ( viral ) infection common associate high mortality rate ICU . To understand interaction important development preventive therapeutic intervention .</brief_summary>
	<brief_title>The Effects Preceding LPS Administration Fluenz-induced Immune Response</brief_title>
	<detailed_description>The Influenza virus know severe course infection systemic effect , associate high mortality rate . Recent work show influenza promotes susceptibility secondary bacterial infection , thereby worsen prognosis . While become clear bacterial infection induce immunosuppressed state immune response viral infection attenuated1 , unknown bacterial infection , sepsis , influence susceptibility immune response influenza . The sepsis-induced immunosuppressive state , call `` immunoparalysis '' , may major contributor increase vulnerability . Because high mortality rate sepsis influenza , main importance understand interaction development putative preventive therapeutic intervention ICU patient . Human endotoxemia represent model systemic inflammation , mimic bacterial sepsis subsequent development immunoparalysis . The live , attenuated , quadrivalent influenza vaccine `` Fluenz™ '' register European Union use surrogate actual influenza infection . In study , want investigate effect endotoxemia challenge Fluenz™-induced inflammatory response present unique vivo data mechanistic interaction systemic LPS follow mucosal Fluenz™ , thereby provide clue regard increased vulnerability towards viral infection septic patient open new avenue investigate therapeutic measure prevent . Furthermore , provide important implication regard safety efficacy vaccine ( post ) septic immunocompromised patient . Objective : Our primary objective investigate effect endotoxin-induced systemic inflammation subsequent development endotoxin tolerance inflammatory response follow Fluenz administration vivo . To evaluate whether effect involve local and/or systemic inflammation , symptom , temperature peak expiratory flow measure . Next , local inflammatory parameter measure nasal wash systemic inflammatory parameter measure blood . Furthermore , want evaluate whether precede endotoxemia influence viral shed influenza nasal wash. Also , change mucosal microbiome , transcriptome metabolome assess . Finally , mitochondrial function mental strength human endotoxemia assess .</detailed_description>
	<criteria>Healthy Preexistent lung disease , include asthma , severe allergic rhinitis Use medication Current smoker 5 packyear history Use recreational drug within 21 day prior start study Use caffeine alcohol within 1 day prior start study Surgery trauma significant blood loss blood donation within 3 month prior start study Participation another clinical trial within 3 month prior start study Frequent nosebleed Recent nasal otologic surgery ( suspect ) influenza infection last year Clinically significant acute ( febrile ) illness common cold within four week prior start study History frequent vasovagal collapse orthostatic hypotension History , sign symptoms cardiovascular disease . History allergic reaction Fluenz™ , egg / gelatin / gentamicin History GuillainBarré Syndrome Cardiac conduction abnormality ECG consist 2nd degree atrioventricular block complex bundle branch block . Hypertension ( define Blood pressure ( RR ) systolic &gt; 160 RR diastolic &gt; 90 ) . Hypotension ( define RR systolic &lt; 100 RR diastolic &lt; 50 ) . Renal impairment ( define plasma creatinin &gt; 120 μmol/l ) . Liver function abnormality : alkaline phosphatase &gt; 230 U/L and/or Alanineaminotransferase ( ALT ) &gt; 90 unit per Liter ( U/L ) Creactive protein ( CRP ) &gt; 20 mg/L , white blood cell count ( WBC ) &gt; 12x109/L Vaccination influenza season Recent vaccination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fluenz</keyword>
	<keyword>innate immune response</keyword>
	<keyword>endotoxin tolerance</keyword>
	<keyword>prim</keyword>
</DOC>